Evidence-based therapy for type 2 diabetes. The best and worst of times
Postgrad Med. 2000 May 1;107(5):27-8, 31-4, 37-40, passim.
doi: 10.3810/pgm.2000.5.1.1064.
Affiliation
- 1 Department of Internal Medicine, Eastern Virginia Medical School of the Medical College, Norfolk 23510, USA.
Abstract
Type 2 diabetes, which is increasing in prevalence, is a multifaceted disease that presents a challenge to the primary care physician. In this article, Drs Flemmer and Vinik review the significant findings of several important clinical trials and present a method of comprehensive staged management to improve the quality of patient care.
MeSH terms
-
Aged
-
Albuminuria / economics
-
Albuminuria / prevention & control
-
Algorithms
-
Diabetes Mellitus, Type 2 / complications*
-
Diabetes Mellitus, Type 2 / drug therapy*
-
Diabetes Mellitus, Type 2 / epidemiology
-
Drug Therapy, Combination
-
Humans
-
Hyperglycemia / etiology
-
Hyperglycemia / prevention & control
-
Hyperlipidemias / complications
-
Hyperlipidemias / prevention & control
-
Hypertension / complications
-
Hypertension / drug therapy
-
Hypolipidemic Agents / therapeutic use*
-
United Kingdom / epidemiology